M. Frénay

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Martin J. van den Bent, Alba A. Brandes, R. Rampling et al. · Journal of Clinical Oncology · 2009 · 569 citations · Full text

Medicine, Oncology, Pharmacology +17

Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force

Riccardo Soffietti, Brigitta G. Baumert, Lorenzo Bello et al. · European Journal of Neurology · 2010 · 502 citations · Full text

Medicine, Neurosurgery, Oncology +17

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases

Laurent Capelle, Denys Fontaine, Emmanuel Mandonnet et al. · Journal of neurosurgery · 2013 · 413 citations

Medicine, Oncology, Surgery +16

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971

Martin J. van den Bent, Alba A. Brandes, Johan Menten et al. · Journal of Clinical Oncology · 2003 · 296 citations

Medicine, Oncology, Surgery +17

Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Khê Hoang‐Xuan, Luc Taillandier, Olivier Chinot et al. · Journal of Clinical Oncology · 2003 · 263 citations

Medicine, Oncology, Pharmacology +15